Posts

After FDA sign-off, Colorado's drug import plan faces tough road ahead

on

Pharma Industry's Reshoring Boom: Massive Investments Amid Tariff Pressures

on

FDA's PreCheck Pilot Program: Aligning on Regulatory Pathways to Avoid Approval Surprises

on

Pharma Investment Surge in US Manufacturing Creates Major Opportunities for CDMOs

on

Drugmakers Push US Expansion After Trump’s 100% Pharma Tariff Threat

on

Rethinking Strategies in Pharma Amidst Supply Chain Disruptions

on

FDA Launches Pilot Program to Prioritize U.S. Generic Drug Manufacturing and Testing

on

Trump Administration Launches Tariff Probe into Medtech and Pharmaceutical Industries

on

Celltrion Acquires Eli Lilly’s New Jersey Manufacturing Site for $330 Million

on

GSK Commits $30 Billion to Bolster U.S. R&D and Manufacturing

on

Recent News on Scaling Up Cell & Gene Therapy Supply Chains (2025)

on

Resilience Through Reinvention: How Pharma is Navigating Uncertainty During Turbulent Times

on

Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO

on

Teva Execs Shrug Off Pharmaceutical Tariff Threat as Turnaround Strategy Rolls Forward

on

Merck’s Enflonsia FDA Approval Spurs Sanofi to Accelerate Beyfortus Supply Ahead of 2025-26 RSV Season

on

Sanofi Commits $20 Billion to US Expansion Amid Industry-Wide Investment Surge

on